 | Up a level |
Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Schlieper, G., Remppis, A., Schwenger, V., Keller, T., Dechend, R., Massberg, S., Baldus, S., Weinreich, T., Hetzel, G., Floege, J., Hoyer, J., Mahfoud, F. and Fliser, D. (2018). Non-vitamin K antagonist oral anticoagulants (NOAC) in chronic kidney disease. Recommendations of the working group Heart-Kidneys, of the German Cardiac Society and the German Society of Nephrology. Nephrologe, 13 (2). S. 91 - 99. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1862-0418
Schlieper, G., Schwenger, V., Remppis, A., Keller, T., Dechend, R., Massberg, S., Baldus, S., Weinreich, T., Hetzel, G., Floege, J., Mahfoud, F. and Fliser, D. (2017). Anticoagulation in patients with chronic kidney disease Recommendations from the working group Heart-Kidney of the German Cardiac Society and the German Society of Nephrology. Internist, 58 (5). S. 512 - 522. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289